VAXZEVRIAの長期安全性に関する日本における市販後調査（PMS）

基本情報

NCT ID

NCT05135455

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

467

治験依頼者名

AstraZeneca

概要

This survey will be conducted for the subjects who participate in the priority survey (cohort survey) conducted by the Scientific Research Group of the Ministry of Health, Labour and Welfare at the initial stage of administration of the COVID-19 vaccination. The present study aims to collect information on serious adverse events or COVID-19 infection observed from 28 days after the last vaccination of VAXZEVRIA up to 12 months after the last vaccination and to evaluate the long-term safety of this vaccine.

対象疾患

依頼者（Sponsor）